inhousefyi
← Back to listings

Senior Director, Field VEOR

Definium TherapeuticsRemote · Posted 2 months ago
Full-timeRemoteEst. 298,532 USD
Apply now

Description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

We are seeking a Senior Director of Field Value Evidence & Outcomes Research (VEOR) to develop and lead the execution of value demonstration and communication strategies and engage in peer-peer discussions which foster optimized patient access with relevant health care decision makers and influencers within US health care ecosystem.

The role will report to the Vice President, Value Evidence and Outcomes Research. The successful candidate is driven, self-sufficient, curious, collaborative, with a bold ambition to contribute to ground-breaking drug development with potential to transform brain health diseases with very high unmet medical need. She/he is a generous collaborator with innovative approaches, and a willingness to learn new concepts while working in a fast-growing, dynamic environment.

Responsibilities:

  • Develop and implement stakeholder engagement strategies for relevant external audiences
  • Develop and execute communication plans that clearly convey the real-world value of the company’s products
  • Cultivate and maintain relationships with key health care decision-makers and influencers, including U.S. payers, academic institutions, key opinion leaders, health system providers, and policy stakeholders
  • Contribute to the development of integrated evidence generation plans by identifying and collecting field-generated real-world data insights to fulfill evidence gaps
  • Partner closely with internal functions—including Clinical Development, Clinical Operations, Policy, Commercial, Market Access, and Medical Affairs—to develop and/or support programs that address broad product access and demand challenges
  • Partner with health system providers, practices, and site of care delivery teams to support site readiness and operationalization of patient care sites, including facilitating access to healthcare economic data, reimbursement pathways, practice economics analyses, and patient services resources that enable successful practice adaption
  • Contribute to account planning with cross-functional field-based teams, identifying areas where value and healthcare economic information can be collected or utilized to support patient access
  • Support and/or deliver the presentation of disease related information, and healthcare economic information to health care decision makers
  • Represent the company at key national and international conferences

Job characteristics:

  • Working in rapidly growing environment with strong focus on real-world evidence generation and customer engagement
  • Being self-motivated and driven
  • Managing a variety of priorities under tight timelines
  • Supporting multiple stakeholders and managing multiple priorities

Requirements:

  • Advanced degree (MS, MPH, MD, PhD, PharmD) in life sciences, health services research, operations science
  • Minimum 7-10 years of experience in field-facing role and applied health economics in an industry setting, preferably in psychiatry or neuroscience related therapeutic areas
  • Excellent knowledge of health care system and market access environment
  • Demonstrated experience and thorough understanding of RWE generation and the applicability of various US datasets and data collection methods across phase 3 /observational and phase IV/post-marketing study design
  • Previous new product launch experience a plus
  • Demonstrated business and scientific acumen
  • Excellent analytic and problem-solving skills
  • Demonstrated ability to understand and effectively communicate scientific information
  • Ability to work independently, with proven oral and written communication skills
  • Ability to work effectively in a fast-paced, collaborative environment
  • Aptitude to closely collaborate and connect with an entirely remote team, willing to travel on a regular basis (projected ~50% - 70% travel)

The starting base pay range for this position is $283,963.00 - $313,100.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.

Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:

  • 100% paid health benefits including Medical, Dental and Vision for you and your dependents
  • 401(k) program with company match and vesting after the turn of the first month after your start date
  • Flexible time off
  • Generous parental leave and some fun fringe perks!

Similar jobs

Senior MSL - East2 months ago

Est. 240,280 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 232,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 273,224 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 240,280 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
Senior MSL - West2 months ago

Est. 240,280 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
MSL - East1 month ago

Est. 202,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
MSL - Mid West1 month ago

Est. 202,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
MSL - West1 month ago

Est. 202,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 176,176 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 245,000 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 175,000 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 172,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote

Est. 229,224 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
Definium TherapeuticsRadnor, Pennsylvania, United States

Est. 97,500 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-time

Est. 80,000 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
Sr Patent Agent4 days ago

Est. 130,000 USD

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments…

Full-timeRemote
Vor BioBoston, Massachusetts, United States

Est. 295,000 USD

Join Us in Tackling Autoimmune Disease at Its Root At Vor, we believe science can do more than manage symptoms. It can change the course of disease. By advancing telitacicept, a first- and potentially best-in-class dual…

Full-time

Est. 272,000 USD

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…

Full-timeRemote
RevanceRemote

Job Summary: Reporting to the Vice President of Clinical Development and Data Science, the Associate Director, Clinical Development will support research activities leading to the expansion of Revance therapeutic product…

Full-timeRemote
Dyne TherapeuticsWaltham, Massachusetts, United States

Est. 215,000 USD

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…

Full-time
Noctrix HealthPleasanton, California, United States

Est. 140,000 USD

Noctrix Health is redefining the treatment of chronic neurological disorders with clinically validated therapeutic wearables. Our team of medical device specialists, neuroscientists, and consumer electronics engineers is…

Full-time
Axsome TherapeuticsNew York City, New York, United States

Est. 270,000 USD

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…

Full-time
Dyne TherapeuticsWaltham, Massachusetts, United States

Est. 259,000 USD

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…

Full-time
Echo NeurotechnologiesSan Francisco, California, United States

Est. 290,000 USD

Company Overview Echo Neurotechnologies is an exciting new startup in the Brain-Computer Interface (BCI) space, driving innovation through advanced hardware engineering and AI solutions. Our mission is to deliver cutting…

Full-time

Est. 390,000 USD

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on…

Full-timeRemote

Est. 374,000 USD

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on…

Full-timeRemote
Dyne TherapeuticsWaltham, Massachusetts, United States

Est. 290,000 USD

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…

Full-time

Est. 261,000 USD

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…

Full-timeRemote
Revolution MedicinesRedwood City, California, United States

Est. 274,500 USD

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…

Full-time
Dyne TherapeuticsWaltham, Massachusetts, United States

Est. 177,000 USD

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…

Full-time